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Abstract
For studying proliferation and determination of survival of cancer cells after irradiation, the multiple MTT assay,
based on the reduction of a yellow water soluble tetrazolium salt to a purple water insoluble formazan dye by
living cells was modified from a single-point towards a proliferation assay. This assay can be performed with a
large number of samples in short time using multi-well-plates, assays can be performed semi-automatically with a
microplate reader. Survival, the calculated parameter in this assay, is determined mathematically. Exponential
growth in both control and irradiated groups was proven as the underlying basis of the applicability of the
multiple MTT assay. The equivalence to a clonogenic survival assay with its disadvantages such as time
consumption was proven in two setups including plating of cells before and after irradiation. Three cell lines (A
549, LN 229 and F 98) were included in the experiment to study its principal and general applicability.
Background
Clonogenic and MTT assays are well-known tests for
evaluation of chemoradiation studies and radiosensitivity
[1-4]. Clonogenic assays are commonly used to investi-
gate survival of irradiated cancer cells, whereas MTT
assays are well known to study chemosensitivity [5] or
toxicity [6] of drugs in human tumor cell lines. The
assay is less common to study survival of cancer cells
after irradiation, in particular when the MTT assay is
performed for studying proliferation of treated cells.
The aim of this study is to compare the well-estab-
lished clonogenic assay with an adapted version of the
MTT proliferation assay to overcome limitations such as
long duration of experiment, low sample throughput,
limited error level and time-consuming counting of
clones.
T h eM T Ta s s a yi sb a s e do nt h ef o r m a t i o no fd a r k -
colored formazan dye by reduction of the tetrazolium
salt MTT by metabolically active cells [7]. After some
incubation, the water-insoluble formazan dye forms
crystals, which can be dissolved in an organic solvent
and the amount can be determined semi-automatically
using a microplate reader. Absorbance readings are
related to the number of cells [8] therefore providing
the possibility to use the MTT assay as a proliferation
assay to assess cell growth after irradiation. In the pre-
sent study our adapted version of the MTT assay is
compared to the clonogenic assay in order to open the
possibility of replacing one by the other.
In the literature, several studies on comparability of
MTT and clonogenic assay can be found. There, the
MTT assay is done as a single-point assay after a defined
time following treatment. In this case, much information
about the growth behavior of the cells is lost (doubling
time, lag phase, growth behavior etc.). In contrast, with
our multiple MTT assay, we collect all those data and
use them for more detailed interpretation.
Materials and methods
Cell line and Culture conditions
Experiments were carried out with A 549 cells (human
NSCLC cell line), LN 229 cells (human glioblastoma cell
line) and F 98 cells (glioblastoma cell line from rats).
Cells were purchased from DSMZ (Braunschweig, Ger-
many) and from ATCC (Manassas, USA). Cells were
cultured in DMEM, supplemented with 10% fetal bovine
serum (FBS), 10 mg/ml antibiotics (penicillin and strep-
tomycin) at 37°C with 5% CO2 in humidified air. Cell
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many). All other chemicals were purchased from Roth
(Karlsruhe, Germany). Cell concentrations in the culture
were adjusted to allow for exponential growth.
Experiment setup
The irradiation cell culture experiment was based on lit-
erature methods [9]. Two essentially different ways of
performing this study can be carried out: Plating of cells
before or after irradiation. Plating before irradiation is
often used as a screening method of sensitivity and effi-
ciency of different treatments. Plating after treatment is
used especially to investigate cell damage repair [9].
Both methods were integrated in this study.
Plating after irradiation
For irradiation experiments, cells were grown in flasks
(25 cm
2) to reach 90% confluence and they were com-
pletely filled with DMEM to avoid artifacts by irradia-
tion through air layers. Treated cells were harvested the
next day using trypsinization, counted and a specific
number of cells (500 and 250 cells) was plated in petri
dishes in triplicate for clonogenic assay. The multiple
MTT assay was performed using 96-well-plates with
4,000 and 2,000 cells (for A 549) per well, respectively.
Plating density for LN 229 was adapted to the size of
the cells.
Plating before irradiation
Cells from a stock culture were plated following appro-
priate dilutions (100 and 50 cells/well for A 549,
adapted to the smaller size of a well compared to a petri
dish) into 6-well-plates as well as into 96-well-plates
(4,000 and 2,000 cells/well for A 549) for multiple MTT
assay and allowed to attach overnight. Irradiation treat-
ment was performed on the next day. Plating density for
LN 229 and F 98 was adapted to the size of the cells.
Proliferation development
Dishes and multi-well-plates were placed in an incuba-
tor. Dishes and 6-well-plates were left there for 9 days
until large clones (> 1 mm) were formed (50 cells or
more). Staining of colonies was done as described below.
Plating density
Commonly, plating densities for clonogenic assays were
adapted paying attention to the situation that the end-
point analysis of this assay is determined optically by
counting clones. Therefore, plating density must not be
too high or clones will coalesce and counting of single
colonies will become impossible. This fact does not play
a role in our multiple MTT assay where analysis is done
photometrically. Here, the only limitation to the validity
of the results of the MTT assay is, when confluence has
been reached or in cases where cell growth has stopped
due to depletion of medium. Previous experiments
showed that plating densities can vary from 500 cells/
well up to 20,000 cells/well (data not shown here).
Irradiation procedure
Irradiation was done using a 6 MV linear accelerator Sie-
mens MD-2 using a clinically calibrated irradiation field
of 20 × 20 cm. The irradiation dose varied between 0 and
15 Gy. For plating after irradiation, cell culture flasks
were completely filled with medium and irradiated hori-
zontally in upright position with RW3-plastic material in
front of the flasks and behind as phantom simulating tis-
sue. For plating before irradiation, the plates were placed
horizontally and covered with RW3-plates as well.
Fixation and staining of colonies
Medium was removed in both dishes and plates, cells
were rinsed with PBS. Fixation and staining of clones
was done with a mixture of 0.5% crystal violet in 50/50
methanol/water for 30 min. Dishes were rinsed with
water and left for drying at room temperature. Counting
of clones was done on the following day.
Multiple MTT assay
The protocol is adapted from literature methods [8].
Briefly, DMEM was supplemented with 100 μlo fM T T
(3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) reagent (c = 0.5 g/l) to each well and incu-
bated for 30 min at 37°C. Thereafter MTT solution was
removed. After addition of 180 μl of DMSO the plates
were incubated for 15 min at 37°C to dissolve the for-
mazan crystals. Absorbance readings of DMSO extracts
were performed at 560 nm with reference of 690 nm
using a Tecan Infinite F 200 microplate reader (Crail-
sheim, Germany).
Results and discussion
Clonogenic assay
After counting clones, plating efficiency (PE) and survi-
val fraction (SF) can be calculated using the following
equations [9]:
PE =
#of coloniesformed
#of cellsseeded
× 100% (1)
SF =
#of coloniesformedafter irradiation
#of cellsseeded × PE
(2)
PE was about 64% for both methods (plating before
and after irradiation) of this study. SF data of all investi-
gated cell lines are shown in Table 1. The survival
curves which have been obtained using different plating
densities were virtually identical and therefore were
averaged.
Multiple MTT assay
MTT assay was done once every day with one column
of each multi-well-plate to follow up exponential growth
Buch et al. Radiation Oncology 2012, 7:1
http://www.ro-journal.com/content/7/1/1
Page 2 of 6of cells. MTT readings are proportional to the number
of cells in-vitro, at least in the phase of exponential
growth. This fact is described in the literature [8] and
was verified in our lab (data not shown). For calculation
of the proliferation survival, only the early exponential
phase of cell growth is used in the following equation (a
derived equation, developed by ourselves):
Survival =2
−
tdelay
tdoublingtime
(3)
tdoubling time = the time period required for a quantity
of cells to double
tdelay = the time period to reach specific absorption
value of control vs. irradiated cells (graphically shown in
Figure 1)
Survival results are shown in Table 2.
In Figure 2a and 2b the survival data for A 549 cells
of clonogenic and multiple MTT assay are plotted
against irradiation dose. The correlation of both assays
is presented in Figure 2c and 2d (R
2 = 0.99 for both).
As expected, the survival curves of both assays show the
same characteristics: the survival depends on the dose of
irradiation and an increase of dose leads to a decrease
in survival, approaching zero in case of plating the cells
after irradiation. Clonogenic and multiple MTT assay
show very similar curve progression, while the multiple
MTT assay gives slightly higher activity results. This fact
m a yb ee x p l a i n e db yt h ep r e s e n c eo fc e l l sw h i c ha r e
alive and show metabolic activity, but poor or no cell
proliferation. Those cells gain more influence in the out-
come of survival in case of the multiple MTT assay. If
the plating of cells is done before irradiation, metabolic
cell activity during the following assay may vary signifi-
cantly. Cells with low metabolic activity and slow prolif-
eration or cells which ceased to proliferate, are excluded
from the assay by washing and trypsinization, when the
plating is done after irradiation. However, as shown in
Figure 2d, the correlation between clonogenic and mul-
tiple MTT assay is still very good and linear.
To prove general applicability of our method, further
cell lines were included in this study. Survival data for
LN 229 cells of clonogenic and multiple MTT assay are
s h o w ni nF i g u r e3 aa n d3 ba sap l o to fs u r v i v a la g a i n s t
irradiation dose. The correlation of the two assays is
s h o w ni nF i g u r e3 ca n d3 d( R
2 =0 . 9 6a n dR
2 =0 . 7 2 ,
respectively). Curve progression of clonogenic survival is
similar to MTT survival, while clonogenic survival
decreased even more than MTT survival. Correlation of
the two assays is still acceptable for plating after irradia-
tion (R
2 = 0.96), for plating before irradiation the corre-
lation quality decreased (R
2 = 0.72).
For the setup ‘plating before irradiation’ A5 4 9c e l l s
showed a very good correlation, LN 229 reduced
Table 1 Clonogenic Assay: Surviving Fraction (SF) of irradiated cells (n = 3 for each experiment); n.d. = not
determined
plating after irradiation plating before irradiation
A 549 250 cells 500 cells mean value S.D. 50 cells 100 cells mean value S.D.
0 Gy 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
1 Gy 67.9% 66.3% 67.1% 1.1% 97.7% 87.2% 92.5% 7.4%
2 Gy 62.3% 60.8% 61.6% 1.0% 90.7% 75.8% 83.3% 10.5%
4 Gy 22.6% 24.7% 23.7% 1.5% 55.8% 34.6% 45.2% 15.0%
6 Gy n.d. 25.6% 19.0% 22.3% 4.7%
8 Gy 5.0% 4.1% 4.6% 0.6% 16.3% 10.4% 13.4% 4.1%
15 Gy 3.4% 0.0% 1.7% 2.4% 2.3% 1.9% 2.1% 0.3%
LN 229 250 cells 500 cells Mean value S.D. 100 cells 200 cells Mean value S.D.
0 Gy 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
1 Gy 90.5% 90.2% 88.9% 3.1% 109.0% 89.5% 99.5% 16.7%
2 Gy 77.0% 60.3% 67.7% 2.2% 38.8% 45.0% 41.9% 12.7%
4 Gy 20.3% 21.1% 20.6% 0.7% 12.9% 14.1% 13.5% 2.4%
6 Gy n.d. 1.6% 3.7% 2.6% 1.7%
8 Gy 1.7% 1.7% 1.7% 0.1% 0.0% 0.0% 0.0% 0.0%
15 Gy 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
F 98 75 cells 100 cells Mean value S.D.
0 Gy n.d. 100.0% 100.0% 100.0%
1 Gy 74.1% 57.4% 65.8% 15.4%
4 Gy 33.3% 41.0% 37.2% 7.7%
6 Gy 33.3% 28.7% 31.0% 8.8%
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line (F 98) in this study to prove the general applicabil-
ity. Survival data are shown in Figure 4b, correlation
data are shown in Figure 4d (R
2 = 0.98) as a good line-
arity between the two assays.
The biggest advantage of performing the multiple
MTT assay is that, due to the fact that our assay is not
only a single-point determination of survival, informa-
tion about growth performance can be acquired easily.
Degrees of direct cell death, lag phase after irradiation
delay
Figure 1 Irradiation induced delay of a cell growth curve: cells were irradiated at t = 20 h after seeding, red curve: control at 0 Gy,
grey curve: irradiated cells with a delay of about 20 h in growth, used as basis for calculation of multiple MTT survival.
Table 2 Multiple MTT assay: Survival of irradiated cells (n = 8 for each experiment); n.d. = not determined
plating after irradiation plating before irradiation
A 549 2000 cells 4000 cells mean value S.D. 2000 cells 4000 cells mean value S.D.
0 Gy 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
1 Gy 64.3% 63.0% 63.7% 0.9% 102.6 & 87.5% 95.0% 10.7%
2 Gy 73.4% 56.5% 65.0% 11.9% 102.5% 88.0% 95.3% 10.2%
4 Gy 28.6% 34.5% 31.6% 4.2% 65.6% 67.6% 66.7% 1.4%
6 Gy n.d. 45.9% 76.8% 61.4% 21.8%
8 Gy 3.2% 13.4% 8.3% 7.3% 27.6% 43.1% 35.3% 11.0%
15 Gy 0.0% 0.1% 0.1% 0.1% 26.3% 31.3% 28.8% 3.6%
LN 229 2500 cells 4000 cells Mean value S.D. 2500 cells 5000 cells Mean value S.D.
0 Gy 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
1 Gy 83.2% 92.3% 87.7% 6.6% 81.9% 87.6% 84.8% 3.9%
2 Gy 62.4% 70.9% 66.7% 7.8% 87.7% 79.9% 83.8% 5.8%
4 Gy 43.0% 50.9% 47.0% 8.5% 63.6% 80.7% 72.2% 3.7%
6 Gy n.d. 30.4% 57.3% 43.9% 5.1%
8 Gy 27.6% 39.8% 33.7% 7.2% 27.1% 48.7% 37.9% 2.6%
15 Gy 15.0% 19.6% 17.3% 5.2% 12.4% 30.7% 21.6% 1.9%
F 98 2500 cells 4000 cells Mean value S.D.
0 Gy n.d. 100.0% 100.0% 100.0%
1G y 93.7% 97.1% 95.4% 7.5%
4G y 69,7% 65.6% 67.6% 5.0%
6G y 46.2% 54.9% 50.6% 4.4%
8G y 28.7% 38.7% 33.7% 3.8%
15 Gy 6.9% 9.7% 8.4% 1.2%
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Figure 2 Survival data (natural logarithm) and correlation of clonogenic and multiple MTT assay for A 549 cells: a & c: plating after
irradiation; b & d: plating before irradiation (cells were irradiated 20 h after seeding).
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Figure 3 Survival data (natural logarithm) and correlation of clonogenic and multiple MTT assay for LN 229 cells: a & c: plating after
irradiation; b & d: plating before irradiation (cells were irradiated 20 h after seeding).
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Page 5 of 6and changes in doubling-time can be measured by
assay-time-points before and after irradiation. Even if
growth becomes exponential again after the lag phase
due to irradiation treatment, doubling-time maybe not
the same as in control [10] in our study but increases
following irradiation with high doses.
Conclusion
Our results suggest that the multiple MTT assay can be
a surrogate of the clonogenic assay in order to deter-
mine survival of irradiated tumor cells. Requirements
for correct interpretation of results are on the one hand
linearity of cell number and MTT reading and on the
other hand, a sufficient number of time points over sev-
eral cell generations in order to predict growth behavior
accurately. The main and only disadvantage of this assay
is that the survival may be overestimated at high radia-
tion doses in the case of plating before irradiation. How-
ever, correlation of multiple MTT and clonogenic assay
is good and trends can be determined anyway; an
important fact when different treatments under equal
irradiation doses are performed. The main advantage of
the multiple MTT assay presented is the opportunity to
obtain precise survival data for high sample throughput
in less time and with less effort than with the conven-
tional colony assay.
In order to establish the multiple MTT assay instead
of a clonogenic assay it is expedient to examine the
transferability of the method first. An experimental
setup reduced to two or three radiation doses should be
sufficient to verify the comparability.
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